319442-18-7 Usage
Uses
Used in Pharmaceutical Industry:
Ethyl 4-chlorothieno[3,2-d]pyrimidine-2-carboxylate is used as a key building block for the preparation of various biologically active compounds and pharmaceuticals. Its versatile chemical structure allows for the development of new drugs with potential therapeutic applications.
Used in Organic Synthesis:
Ethyl 4-chlorothieno[3,2-d]pyrimidine-2-carboxylate is used as a valuable intermediate in the synthesis of complex organic molecules. Its reactivity and compatibility with various synthetic methods make it an essential component in the creation of novel chemical entities.
Used in Drug Discovery:
Ethyl 4-chlorothieno[3,2-d]pyrimidine-2-carboxylate is used as a starting material for the development of new drugs, particularly in the search for anti-inflammatory and anti-cancer agents. Its demonstrated potential in preclinical studies makes it a promising candidate for further research and development.
Used in Medicinal Chemistry Research:
Ethyl 4-chlorothieno[3,2-d]pyrimidine-2-carboxylate is used as a subject of study in medicinal chemistry research. Its unique properties and potential applications contribute to the understanding of molecular interactions and the design of new therapeutic agents.
Check Digit Verification of cas no
The CAS Registry Mumber 319442-18-7 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 3,1,9,4,4 and 2 respectively; the second part has 2 digits, 1 and 8 respectively.
Calculate Digit Verification of CAS Registry Number 319442-18:
(8*3)+(7*1)+(6*9)+(5*4)+(4*4)+(3*2)+(2*1)+(1*8)=137
137 % 10 = 7
So 319442-18-7 is a valid CAS Registry Number.
InChI:InChI=1/C9H7ClN2O2S/c1-2-14-9(13)8-11-5-3-4-15-6(5)7(10)12-8/h3-4H,2H2,1H3
319442-18-7Relevant articles and documents
ALKYNYL ALCOHOLS AND METHODS OF USE
-
Paragraph 0460; 0461, (2015/03/04)
The invention relates to compounds of Formula (0): wherein A1-A8, R4 and R5 each has the meaning as described herein. Compounds of Formula (0) and pharmaceutical compositions thereof are useful in the treatment of diseases and disorders in which undesired or over-activation of NF-kB signaling is observed.
ALKYNYL ALCOHOLS AND METHODS OF USE
-
Page/Page column 122, (2015/03/13)
The invention relates to compounds of Formula (0): wherein A1-A8, R4 and R5 each has the meaning as described herein. Compounds of Formula (0) and pharmaceutical compositions thereof are useful in the treatment of diseases and disorders in which undesired or over-activation of NF-kB signaling is observed.
THIENOPYRIDINE AND THIENOPYRIMIDINE COMPOUNDS AND METHODS OF USE THEREOF
-
Page/Page column 90, (2012/03/26)
Provided herein are thienopyridine and thienopyrimidine compounds of formula (I) for treatment of JAK kinase mediated diseases, including JAK2 kinase-, JAK3 kinase- or TYK2 kinase-mediated diseases. Also provided are pharmaceutical compositions comprising
Thieno-and furopyrimidine derivatives as A2A-receptor antagonists
-
Page column 89, (2010/02/08)
Compounds of formula (I): wherein X is S. Compounds can be used for treating a disorder in which the blocking of purine receptors is beneficial.